BostonGene has won four awards in the Research & Development, Product Launches, and Innovation categories in the 2025 ...
Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...
Nova Pneuma Inc. ("NPI"), the Delaware incorporated and wholly owned subsidiary of Lee's Pharmaceutical Holdings Limited ...
Based on research and analysis of the global microecology market, as well as the evaluation of relevant companies in the ...
Pharmaceutical Technology on MSN
Investors bet on newer technology and indications for CGTs
Safety, durability and scalability are some of the main factors driving investment decisions in the cell and gene therapy ...
He instructed officials to maintain continuous communication with every investor and ensure there is no scope for delay at any level ...
Technological advancements in synthetic chemistry, bioproduction, and containment are enhancing the feasibility of developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback